Cargando…
Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
IMPORTANCE: Clinical guidelines currently recommend against amyloid imaging for cognitively unimpaired persons. The goal of Alzheimer’s disease (AD) prevention, together with advances in understanding the pathophysiology of AD, however, has led to trials testing drugs in cognitively unimpaired perso...
Autores principales: | Largent, Emily A., Harkins, Kristin, van Dyck, Christopher H., Hachey, Sara, Sankar, Pamela, Karlawish, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018056/ https://www.ncbi.nlm.nih.gov/pubmed/32053667 http://dx.doi.org/10.1371/journal.pone.0229137 |
Ejemplares similares
-
Response to “Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure”
por: Grill, Joshua D., et al.
Publicado: (2019) -
Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
por: Grill, Joshua D., et al.
Publicado: (2018) -
‘That would be dreadful’: The ethical, legal, and social challenges of sharing your Alzheimer’s disease biomarker and genetic testing results with others
por: Largent, Emily A, et al.
Publicado: (2021) -
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
por: Harkins, Kristin, et al.
Publicado: (2015) -
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)